Skip to content

Alicia Burns, MD

NPI 1437736485ActiveIndividual· Internal Medicine, Pulmonary Disease· Salt Lake City, UT

Internal Medicine, Pulmonary Disease (MD) in Salt Lake City, Utah, licensed in UT and NH, with an NPI issued in March 2021. Their prescriptions cost Medicare Part D more than their services did: $58,300 for 506 claims, against $3,552 paid for services in 2024. Octapharma USA, Inc. reported $22.52 in payments in 2025, mostly food and beverage.

Overview

NPI1437736485
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 25, 2021
Last updated in NPPESMar 11, 2025
Certified by providerMar 7, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Pulmonary Disease (UT)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients45
Services billed80 across 7 procedure codes
Paid by Medicare$3,552

Part D prescriptions in 2024

Prescriptions (claims)506 · 1,100 30-day fills
Patients88
Total drug cost$58,300
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$22.52 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Octapharma USA, Inc.$22.521

What the 2025 payments were for

  • Food and Beverage$22.52 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Salt Lake City

All Internal Medicine, Pulmonary Disease providers in Utah →